NCT02549937 2024-07-10A Multi-Center, Open-Label Study of Surufatinib (HMPL-012) in Patients With Advanced Solid TumorsHutchmedPhase 1/2 Completed130 enrolled 30 charts
NCT02402062 2020-07-27A Study to Assess the Safety and the Efficacy of the Combination of TH-302 and Sunitinib in Neuroendocrine Pancreatic TumoursGrupo Espanol de Tumores NeuroendocrinosPhase 2 Completed17 enrolled 55 charts
NCT00958841 2016-07-26Study of Pasireotide in Patients With Rare Tumors of Neuroendocrine OriginNovartisPhase 2 Terminated118 enrolled 11 charts
NCT01628913 2016-04-07Efficacy and Safety of BEZ235 Compared to Everolimus in Patients With Advanced Pancreatic Neuroendocrine TumorsNovartisPhase 2 Terminated62 enrolled 7 charts
NCT00538850 2014-03-05Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainINSYS Therapeutics IncPhase 3 Completed130 enrolled 9 charts